Galeterone
98%
- Product Code: 60313
CAS:
851983-85-2
| Molecular Weight: | 388.55 g./mol | Molecular Formula: | C₂₆H₃₂N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD16660907 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Galeterone is primarily investigated for its application in the treatment of prostate cancer, particularly castration-resistant prostate cancer (CRPC). It functions as a multi-target agent, inhibiting androgen receptor signaling, which is crucial for the growth and survival of prostate cancer cells. By blocking the androgen receptor, galeterone reduces the proliferation of cancer cells and induces apoptosis. Additionally, it suppresses the production of androgens in the body, further limiting the fuel for cancer progression. Its unique mechanism of action makes it a promising candidate for patients who have developed resistance to traditional androgen deprivation therapies. Clinical trials have explored its efficacy and safety, aiming to provide a new therapeutic option for advanced prostate cancer patients.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.025 | 10-20 days | ฿9,297.00 |
+
-
|
| 0.100 | 10-20 days | ฿18,369.00 |
+
-
|
Galeterone
Galeterone is primarily investigated for its application in the treatment of prostate cancer, particularly castration-resistant prostate cancer (CRPC). It functions as a multi-target agent, inhibiting androgen receptor signaling, which is crucial for the growth and survival of prostate cancer cells. By blocking the androgen receptor, galeterone reduces the proliferation of cancer cells and induces apoptosis. Additionally, it suppresses the production of androgens in the body, further limiting the fuel for cancer progression. Its unique mechanism of action makes it a promising candidate for patients who have developed resistance to traditional androgen deprivation therapies. Clinical trials have explored its efficacy and safety, aiming to provide a new therapeutic option for advanced prostate cancer patients.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :